JPY7,213.00
1.73%
Tokyo, Nov 01, 07:15 am CET
ISIN
JP3519400000
Symbol
4519
Index
Sector
Industry

Chugai Pharmaceutical Target price 2024 - Analyst rating & recommendation

Chugai Pharmaceutical Classifications & Recommendation:

Buy
43%
Hold
50%
Sell
7%

Chugai Pharmaceutical Price Target

Target Price JPY7,250.00
Price JPY7,213.00
Potential
Number of Estimates 11
11 Analysts have issued a price target Chugai Pharmaceutical 2025 . The average Chugai Pharmaceutical target price is JPY7,250.00. This is higher than the current stock price. The highest price target is
JPY9,900.00 37.25%
register free of charge
, the lowest is
JPY4,500.00 37.61%
register free of charge
.
A rating was issued by 14 analysts: 6 Analysts recommend Chugai Pharmaceutical to buy, 7 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Chugai Pharmaceutical stock has an average upside potential 2025 of . Most analysts recommend the Chugai Pharmaceutical stock at Hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion JPY 1,111.37 1,137.59
11.79% 2.36%
EBITDA Margin 40.26% 48.36%
10.29% 20.13%
Net Margin 29.29% 33.96%
1.48% 15.94%

12 Analysts have issued a sales forecast Chugai Pharmaceutical 2024 . The average Chugai Pharmaceutical sales estimate is

JPY1.1t
Unlock
. This is
0.42% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
JPY1.2t 6.63%
Unlock
, the lowest is
JPY1.1t 4.03%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 JPY1.1t 11.79%
2024
JPY1.1t 2.36%
Unlock
2025
JPY1.2t 1.86%
Unlock
2026
JPY1.2t 4.76%
Unlock
2027
JPY1.4t 12.33%
Unlock
2028
JPY1.6t 13.94%
Unlock

9 Analysts have issued an Chugai Pharmaceutical EBITDA forecast 2024. The average Chugai Pharmaceutical EBITDA estimate is

JPY550b
Unlock
. This is
2.05% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
JPY576b 6.93%
Unlock
, the lowest is
JPY513b 4.85%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 JPY447b 20.87%
2024
JPY550b 22.95%
Unlock
2025
JPY560b 1.87%
Unlock
2026
JPY596b 6.29%
Unlock
2027
JPY622b 4.41%
Unlock
2028
JPY698b 12.23%
Unlock

EBITDA Margin

2023 40.26% 10.29%
2024
48.36% 20.13%
Unlock
2025
48.36% 0.00%
Unlock
2026
49.07% 1.47%
Unlock
2027
45.61% 7.05%
Unlock
2028
44.93% 1.49%
Unlock

6 Chugai Pharmaceutical Analysts have issued a net profit forecast 2024. The average Chugai Pharmaceutical net profit estimate is

JPY386b
Unlock
. This is
0.17% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
JPY440b 13.77%
Unlock
, the lowest is
JPY345b 10.95%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 JPY326b 13.10%
2024
JPY386b 18.67%
Unlock
2025
JPY400b 3.43%
Unlock
2026
JPY438b 9.67%
Unlock
2027
JPY552b 25.91%
Unlock
2028
JPY629b 14.09%
Unlock

Net Margin

2023 29.29% 1.48%
2024
33.96% 15.94%
Unlock
2025
34.48% 1.53%
Unlock
2026
36.10% 4.70%
Unlock
2027
40.47% 12.11%
Unlock
2028
40.52% 0.12%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share JPY 197.83 234.77
13.10% 18.67%
P/E 30.72
EV/Sales 9.70

6 Analysts have issued a Chugai Pharmaceutical forecast for earnings per share. The average Chugai Pharmaceutical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

JPY234.77
Unlock
. This is
0.17% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
JPY267.57 13.77%
Unlock
, the lowest is
JPY209.42 10.95%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 JPY197.83 13.10%
2024
JPY234.77 18.67%
Unlock
2025
JPY242.82 3.43%
Unlock
2026
JPY266.31 9.67%
Unlock
2027
JPY335.31 25.91%
Unlock
2028
JPY382.55 14.09%
Unlock

P/E ratio

Current 30.67 40.49%
2024
30.72 0.16%
Unlock
2025
29.70 3.32%
Unlock
2026
27.09 8.79%
Unlock
2027
21.51 20.60%
Unlock
2028
18.86 12.32%
Unlock

Based on analysts' sales estimates for 2024, the Chugai Pharmaceutical stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
10.43
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 9.66 82.95%
2024
9.70 0.37%
Unlock
2025
9.52 1.82%
Unlock
2026
9.09 4.54%
Unlock
2027
8.09 10.97%
Unlock
2028
7.10 12.24%
Unlock

P/S ratio

Current 10.39 80.36%
2024
10.43 0.42%
Unlock
2025
10.24 1.82%
Unlock
2026
9.78 4.54%
Unlock
2027
8.71 10.97%
Unlock
2028
7.64 12.24%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today